$SEM

Breighner Robert G. JR sold (to issuer) $303K of SEM

Breighner Robert G. JR (SENIOR VICE PRESIDENT) sold (to issuer) 18,362 shares of SELECT MEDICAL HOLDINGS CORP (SEM) at $16.50 ($0.30M total) on 2026-06-30.

Original reporting
SEC EDGAR · Breighner Robert G. JR
Published Jul 1, 2026, 6:13 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 6:16 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SEM
Neutral
medium confidence
Mentioned
$SEM
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SEMNeutralLow
01

Why it matters

The newest fact is the disclosed sale to the issuer of 18,362 shares at $16.50 on 2026-06-30; no other company-specific news is included.

02

Market read

Traders may note insider selling, but the filing lacks fundamental catalysts and is unlikely to drive a sustained repricing by itself.

03

What to watch

The article does not state the reason for the sale, whether it was tax-related, or any broader corporate action; without those details, signal quality is low.

Relevance 4/10Novelty 3/10Timing: filed after-hours on 2026-07-01 (SEC Form 4 disclosure)

Background

The article is an SEC Form 4 insider transaction disclosure for Select Medical Holdings Corp (SEM).

Company-level read

Ticker impact

$SEMNeutralMedium confidence
Context

Select Medical Holdings insider Robert G. Breighner Jr sold 18,362 shares to the issuer for about $303K on 2026-06-30 (Form 4).

Expected impact

Likely minimal immediate price impact; any effect would be second-order via sentiment rather than new fundamentals.

Evidence & confidence

The filing is a Form 4 insider transaction with modest dollar value and no accompanying operational/regulatory/financial catalyst in the text.

Market effects

No sector-level read-across provided; this is company-specific insider dealing.

None indicated.

None indicated.

Counterpoint

Because the transaction is a sale to the issuer (often tied to administrative/plan mechanics) and the insider ends with 0 shares, it may reflect liquidity/plan execution rather than bearish expectations.

Key entities

  • SELECT MEDICAL HOLDINGS CORP

    Subject of the Form 4 insider transaction disclosure.

  • Breighner Robert G. JR

    Senior Vice President who sold shares to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law or fiduciary-duty issues in deals involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale for $16.50/share, and TopBuild’s proposed acquisition by QXO. The firm also flagged QXO’s merger with TopBuild and said it may seek higher consideration or additional disclosures.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law violations and fiduciary-duty breaches involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale to a consortium led by its executives/directors for $16.50/share, and TopBuild’s proposed deal with QXO. TopBuild holders would choose $505 cash or 20.2 QXO shares per share.